FreeIn the Archives A history of the ACS Great American Smokeout; oral histories from Duke Cancer Institute November 18, 2022Vol.48 No.42
A brief report sets forth a “new normal,” lets NCI start to streamline clinical trials November 11, 2022Vol.48 No.41By Paul Goldberg
Conversation with The Cancer Letter NCI’s Doroshow: “These recommendations are something that we can implement right away” November 11, 2022Vol.48 No.41By Paul Goldberg
NCI Bertagnolli sets out eight “core principles” for NCI: “We’ve got to be nimbler, faster” November 11, 2022Vol.48 No.41
Cancer History ProjectConversation with The Cancer LetterFree Craig Jordan on discovering tamoxifen’s role in breast cancer—and a lifetime of innovation November 11, 2022Vol.48 No.41By Alexandria Carolan
FreeIn the Archives Rutgers archives: Shridar Genesan, Tiki Barber, pancreatic cancer retrospectives November 11, 2022Vol.48 No.41
Conversation with The Cancer Letter Pavan Reddy tells us how his research dovetails with running Baylor’s Dan L Duncan cancer center November 04, 2022Vol.48 No.40By Paul Goldberg
Regulatory News ODAC considers the first application based wholly on RWE methodology—and nixes it unanimously November 04, 2022Vol.48 No.40By Paul Goldberg
Conversation with The Cancer Letter Children’s National and UCL team receives $25M Grand Challenges award to study CAR T in pediatric solid tumors November 04, 2022Vol.48 No.40By Jacquelyn Cobb
FreeIn the Archives Tobacco Awareness Month: Smoking in pharmaceutical advertising November 04, 2022Vol.48 No.40
